• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. OPTIPAC-S 80 REFOBACIN CEMENT; BONE CEMENT, ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. OPTIPAC-S 80 REFOBACIN CEMENT; BONE CEMENT, ANTIBIOTIC Back to Search Results
Model Number N/A
Device Problems No Flow (2991); Temperature Problem (3022)
Patient Problem No Information (3190)
Event Date 10/11/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(4).(b)(6).The product within this report is a combination product.The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.Not returned to manufacturer.
 
Event Description
It was reported the powder inside the cartridge appeared hard.It could not be penetrated by the plunger easily and only with high force.If this is attempted and the monomer is sucked in completely, the cement takes 25 minutes to harden at room temperature.A delay of 60 minutes was reported.No further information has been reported.
 
Manufacturer Narrative
This follow-up report is being filled to relay additional information, which was unknown at the time of the initial medwatch.The following sections were updated: if follow-up, what type?, device evaluated by mfr, evaluation codes.Reserve sample from the same lot was evaluated and the reported event was confirmed.Testing was performed under standardized conditions and the sample tested showed the polymer powder was compact and the setting time was too long.Device history record (dhr) was reviewed and no discrepancies were found.Root cause was unable to be determined at this time; further investigation has been initiated to address reported issue.A summary of the investigation has been sent to the complainant.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIPAC-S 80 REFOBACIN CEMENT
Type of Device
BONE CEMENT, ANTIBIOTIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
Manufacturer (Section G)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key7037090
MDR Text Key92994400
Report Number3006946279-2017-00246
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
PK150850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date08/31/2018
Device Model NumberN/A
Device Catalogue Number4732501165-1
Device Lot NumberA705C05628
Other Device ID NumberSEE H10 NARRATIVE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/17/2017
Initial Date FDA Received11/16/2017
Supplement Dates Manufacturer Received12/07/2017
Supplement Dates FDA Received01/05/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/30/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
Patient Outcome(s) Other;
-
-